Skip to main content

Advertisement

Log in

Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aims

The expression of signal transducers and activators of transcription 3 (STAT3) is increased in Crohn’s disease (CD), and nuclear translocated STAT3 is also found in the disease. However, the role of STAT3 protein on the pathogenesis of CD is not clear. This study was executed to investigate the role of STAT3 protein on the pathogenesis of trinitrobenzene sulfonic acid (TNBS)-induced colitis, the pathogenesis of which is CD-like.

Methods

TNBS-induced colitis was produced, and STAT3 antisense oligonucleotide was administrated intracolonically during the early phase of colitis. The mice were killed 7 days later, and the expressions of STAT3 and phosphorylated STAT3 were identified by Western blot and immunofluorescence. The lamina propria mononuclear cells (LPMCs) were isolated freshly, and the percent of cell death and the expressions of Bcl-2 and Bax in LPMCs were evaluated. Colonic tissue damage and the production of inflammatory cytokines were measured also.

Results

Administration of STAT3 antisense oligonucleotide effectively inhibited STAT3 expression and phosphorylation in inflamed colonic mucosa of colitis. The mice that were administered STAT3 antisense oligonucleotide showed less colonic tissue damage with decreased production of inflammatory cytokines such as TNF-α and INF-γ in mucosa compared with that of those TNBS-induced colitis. Administration of STAT3 antisense oligonucleotide successfully induced apoptosis of LPMCs and counteracted the unbalanced expressions of Bcl-2 and Bax in LPMCs from colitis.

Conclusions

STAT3 activation may play an important role in the inflammatory process of TNBS-induced colitis, and inhibiting STAT3 activation during the early phase of the inflammatory response may have a beneficial effect on the colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ASON:

antisense oligonucleotide

CD:

Crohn’s disease

INF-γ:

interferon γ

IL-6:

interleukin-6

LPMCs:

lamina propria mononuclear cells

MMAS:

mismatch antisense oligonucleotide

MPO:

myeloperoxidase

NF-κB:

nuclear factor-kappa B

PMN:

polymorphonuclear

pSTAT3:

phosphorylated STAT3

STAT:

signal transducers and activators of transcription

TNBS:

trinitrobenzene sulfonic acid

TNF-α:

tumor necrosis factor-α

References

  1. Oliva-Hemker M, Fiocchi C (2002) Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis 8:112–128

    Article  PubMed  Google Scholar 

  2. Cheung O, Regueiro MD (2003) Inflammatory bowel disease emergencies. Gastroenterol Clin North Am 32:1269–1288

    Article  PubMed  Google Scholar 

  3. Niessner M, Volk BA (1995) Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101:428–435

    Article  PubMed  CAS  Google Scholar 

  4. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477–484

    Article  PubMed  CAS  Google Scholar 

  5. Thanos D, Maniatis T (1995) NF-kappa B: a lesson in family values. Cell 80:529–532

    Article  PubMed  CAS  Google Scholar 

  6. Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630–1635

    Article  PubMed  CAS  Google Scholar 

  7. Schindler C, Darnell JE Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64:621–651

    Article  PubMed  CAS  Google Scholar 

  8. Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med 2:381–392

    Article  PubMed  CAS  Google Scholar 

  9. Ina K, Itoh J, Kusugami K, Yamaguchi T, Kyokane K, Imada A, Binion DG, Musso A, West GA, Dobrea GM, McCormick TS, Lapetina EG, Levine AD, Ottaway CA, Fiocchi C (1999) Resistance of Crohn’s disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 163:1081–1090

    PubMed  CAS  Google Scholar 

  10. Ayroldi E, Zollo O, Cannarile L, D’Adamio F, Grohmann U, Delfino DV, Riccardi C (1998) Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death. Blood 92:4212–4219

    PubMed  CAS  Google Scholar 

  11. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 6:583–588

    Article  PubMed  CAS  Google Scholar 

  12. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease. Gastroenterology 126:989–996

    Article  PubMed  CAS  Google Scholar 

  13. Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, Lehr HA, Schmidt J, Neurath MF (2005) Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 100:64–72

    Article  PubMed  CAS  Google Scholar 

  14. Musso A, Dentelli P, Carlino A, Chiusa L, Repici A, Sturm A, Fiocchi C, Rizzetto M, Pegoraro L, Sategna-Guidetti C, Brizzi MF (2005) Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm Bowel Dis 11:91–98

    Article  PubMed  Google Scholar 

  15. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10(1):39–49

    Article  PubMed  CAS  Google Scholar 

  16. Welte T, Zhang S, Wang T, Zhang Z, Hesslein DG, Yin Z, Kano A, Iwamoto Y, Li E, Craft JE, Bothwell AL, Fikrig E, Koni PA, Flavell RA, Fu XY (2003) STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci USA 100:1879–1884

    Article  PubMed  CAS  Google Scholar 

  17. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, Koide Y (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123:1912–1922

    Article  PubMed  CAS  Google Scholar 

  18. Karras JG, McKay RA, Lu T, Pych J, Frank DA, Rothstein TL, Monia BP (2000) STAT3 regulates the growth and immunoglobulin production of BCL1 B cell lymphoma through control of cell cycle progression. Cell Immunol 202:124–135

    Article  PubMed  CAS  Google Scholar 

  19. McKay RA, Miraglia LJ, Cummins LL, Owens SR, Sasmor H, Dean NM (1999) Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. J Biol Chem 274:1715–1722

    Article  PubMed  CAS  Google Scholar 

  20. Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA, Morelli A (2003) Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124:1381–1394

    Article  PubMed  CAS  Google Scholar 

  21. Wallace JL (1987) Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. Prostaglandins 34:311–323

    Article  PubMed  CAS  Google Scholar 

  22. Newberry RD, Stenson WF, Lorenz RG (1999) Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 5:900–906

    Article  PubMed  CAS  Google Scholar 

  23. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2:998–1004

    Article  PubMed  CAS  Google Scholar 

  24. Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, Shanahan WR Jr (1998) A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn’s disease. Gastroenterology 114:1133–1142

    Article  PubMed  CAS  Google Scholar 

  25. Spiik AK, Ridderstad A, Axelsson LG, Midtvedt T, Bjork L, Pettersson S (2002) Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides. Int J Colorectal Dis 17:223–232

    Article  PubMed  Google Scholar 

  26. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R (2002) Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 62:6659–6666

    PubMed  CAS  Google Scholar 

  27. Takahashi T, Abe H, Arai H, Matsubara T, Nagai K, Matsuura M, Iehara N, Yokode M, Nishikawa S, Kita T, Doi T (2005) Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. J Biol Chem 280:7100–7106

    Article  PubMed  CAS  Google Scholar 

  28. Walker JG, Smith MD (2005) The Jak-STAT pathway in rheumatoid arthritis. J Rheumatol 32:1650–1653

    PubMed  CAS  Google Scholar 

  29. O’shea JJ (2004) Targeting the Jak/STAT pathway for immunosuppression. Ann Rheum Dis 63(Suppl 2):ii67–ii71

    Article  PubMed  CAS  Google Scholar 

  30. Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A (2001) Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 108:1781–1788

    Article  PubMed  CAS  Google Scholar 

  31. Lovato P, Brender C, Agnholt J, Kelsen J, Kaltoft K, Svejgaard A, Eriksen KW, Woetmann A, Odum N (2003) Constitutive STAT3 activation in intestinal T cells from patients with Crohn’s disease. J Biol Chem 278:16777–16781

    Article  PubMed  CAS  Google Scholar 

  32. Han X, Sosnowska D, Bonkowski EL, Denson LA (2005) Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis. Gastroenterology 129:185–203

    Article  PubMed  CAS  Google Scholar 

  33. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614–620

    Article  PubMed  CAS  Google Scholar 

  34. Raff MC (1992) Social controls on cell survival and cell death. Nature 356:397–400

    Article  PubMed  CAS  Google Scholar 

  35. Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Ropke C, Odum N (1999) Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13:735–738

    Article  PubMed  CAS  Google Scholar 

  36. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF (2001) Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci USA 98:1543–1548

    Article  PubMed  CAS  Google Scholar 

  37. Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, Strober W (2001) Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 22:21–26

    Article  PubMed  CAS  Google Scholar 

  38. Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K (2000) Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 120:51–58

    Article  PubMed  CAS  Google Scholar 

  39. Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Muller-Newen G (2003) Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 170:3263–3272

    PubMed  CAS  Google Scholar 

  40. Dieleman LA, Elson CO, Tennyson GS, Beagley KW (1996) Kinetics of cytokine expression during healing of acute colitis in mice. Am J Physiol 271:G130–G136

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to PinJin Hu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bai, A., Hu, P., Chen, J. et al. Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis. Int J Colorectal Dis 22, 625–635 (2007). https://doi.org/10.1007/s00384-006-0229-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-006-0229-z

Keywords

Navigation